This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: The Driscoll Firm, P.C.
The Driscoll Firm, P.C., is representing 38 plaintiffs named in the lawsuit filed in St. Clair County Circuit Court in Illinois, alleging that the manufacturer of Actos failed to warn of an increased risk of bladder cancer associated with the diabetes medication.
St. Louis, MO (PRWEB) February 23, 2013
Nationally recognized drug injury lawyer John J. Driscoll announced today that his firm is representing 38 plaintiffs who have filed a lawsuit in St. Clair County Circuit Court in Illinois against Takeda Pharmaceuticals U.S.A, Inc., the manufacturer of the Actos diabetes drug.
According to the lawsuit, the plaintiffs claim they were diagnosed with bladder cancer after consuming Actos, or pioglitazone, which the U.S. Food and Drug Administration (FDA) has approved for use in improving control of blood sugar in adults with type 2 diabetes mellitus.
Their illness has forced them to pay undue medical costs as well as to experience physical pain, mental anguish and a loss of enjoyment of life, the plaintiffs allege in the complaint.
In June 2011, the FDA issued a safety communication, informing the public that the use of Actos for more than one year “may be associated with an increased risk of bladder cancer.” The FDA also mandated a labeling change to include information about this risk.
In the complaint (Case No. 13-L-16), which was filed on January 9, 2013, the plaintiffs allege that they were unaware of that risk at the time they used the medication.
The lawsuit asserts claims for failure to provide a proper warning as well as strict liability, negligence, defective design, breach of express warranty and breach of implied warranty.
The lawsuit has been reported on by The Madison-St. Clair Record legal journal.
Driscoll, the founder of The Driscoll Firm, P.C., represents plaintiffs across the United States in product liability and personal injury litigation, including cases involving dangerous pharmaceuticals and defective medical devices.
The attorney urged Actos users to be on alert for symptoms of bladder cancer, which the FDA identifies as blood or red color in urine, the urgent need to urinate, pain while urinating and pain in the back or lower abdomen. He also noted that the FDA has recommended that doctors not prescribe Actos to those with active bladder cancer or a prior history of the disease.
For legal and medical updates about Actos, concerned patients and family members should visit the law firm’s website, SettlementHelpers.com, Driscoll said.
About The Driscoll Firm, P.C.
The Driscoll Firm, P.C., is dedicated to fighting for the rights of people and families injured by the wrongful acts of individuals and companies. The firm is currently investigating national injury claims involving product liability, defective drugs, dangerous medical devices, medical malpractice, car accidents, premises liability, spinal cord injuries, birth injuries, cerebral palsy, brain injuries, Erb's palsy and other circumstances that have caused serious injury or death. The Driscoll Firm, P.C., is based at 211 N. Broadway, 40th Floor, St. Louis, MO, 63102, and serves clients nationwide. To learn more, call (800) 305-9800 or use the firm’s online contact form. All initial consultations are free and confidential.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebdrug-injury-lawyer/actos-lawsuit/prweb10461779.htm